1. Biliverdin reductase and bilirubin in hepatic disease
   Lauren Weaver et al, 2018, American Journal of Physiology-Gastrointestinal and Liver Physiology CrossRef
2. Aryl-Hydrocarbon Receptor as a Potential Target for Anticancer Therapy
   J. E. Vorontsova et al, 2019, Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry CrossRef
3. Aryl-hydrocarbon receptor as a potential target for anticancer therapy
   J.E. Vorontsova et al, 2018, Biomeditsinskaya Khimiya CrossRef
4. Towards Resolving the Pro- and Anti-Tumor Effects of the Aryl Hydrocarbon Receptor
   Supraja Narasimhan et al, 2018, International Journal of Molecular Sciences CrossRef
5. From Suppressor T Cells to Regulatory T Cells: How the Journey that Began with the Discovery of the Toxic Effects of TCDD Led to Better Understanding of the Role of AhR in Immunoregulation
   Narendra Prasad Singh et al, 2020, International Journal of Molecular Sciences CrossRef
6. Anti-cancer Dynamics of Natural Phytochemical Inhibitors of Cyclin-Dependent Kinases
   Shyam N. Sundar et al, 2020, Natural Products for Cancer Chemoprevention CrossRef